Low grade glioma
MONDO:0021637A grade I or grade II glioma arising from the central nervous system. This category includes pilocytic astrocytoma, diffuse astrocytoma, subependymal giant cell astrocytoma, ependymoma, oligodendroglioma, oligoastrocytoma, and angiocentric glioma.
Also known as: benign glioma, glioma, benign, low grade glioma, low-grade glioma
1702 clinical trials for this condition and its sub-types, 71 tagged with Low grade glioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Low grade glioma
-
Grade II glioma 28 trials · 179 incl. sub-types
5 sub-types
- Ependymoma 87 trials · 89 incl. sub-types Sub-types →
- Oligodendroglioma 62 trials Sub-types →
- Diffuse astrocytoma 25 trials · 28 incl. sub-types Sub-types →
- Oligoastrocytoma 6 trials · 15 incl. sub-types Sub-types →
- Chordoid glioma of the third ventricle 1 trial
-
Schwannoma 9 trials · 42 incl. sub-types
10 sub-types
- Acoustic neuroma 35 trials
- Schwannomatosis 3 trials Sub-types →
- Cellular schwannoma 0 trials
- Melanotic neurilemmoma 0 trials Sub-types →
- Microcystic/reticular schwannoma 0 trials
- Peripheral nerve schwannoma 0 trials Sub-types →
- Plexiform schwannoma 0 trials
- Schwannoma of twelfth cranial nerve 0 trials
- Sympathetic neurilemmoma 0 trials
- Trigeminal schwannoma 0 trials
-
Low grade astrocytic tumor 1 trial · 41 incl. sub-types
1 sub-type
- Low-grade astrocytoma 5 trials · 41 incl. sub-types Sub-types →
-
Childhood low-grade glioma 7 trials
-
Angiocentric glioma 1 trial
Most studied deeper sub-types
-
New hope for kids with brain tumors: targeted drug mirdametinib enters trial
Disease control Recruiting nowThis study tests a drug called mirdametinib in children, adolescents, and young adults with low-grade glioma, a type of brain tumor. The drug is designed to cross into the brain and block a protein that helps tumors grow. The trial has two phases: Phase 1 finds the safest dose, a…
Phase 1/2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New drug could replace chemo for kids with brain tumor
Disease control Recruiting nowThis study tests whether a targeted drug called selumetinib works as well as standard chemotherapy (carboplatin and vincristine) for children and young adults with a slow-growing brain tumor called low-grade glioma. Participants must be 2 to 21 years old and have a tumor without …
Phase 3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can we stop these cancer drugs without the tumor coming back?
Disease control Recruiting nowThis study looks at whether patients with a certain type of slow-growing brain tumor (low-grade glioma with a BRAF V600 mutation) can safely stop or reduce their dose of two targeted drugs, dabrafenib and trametinib, after 12-24 months of treatment. About 96 participants will eit…
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Proton beam therapy tested for brain tumors: could spare healthy tissue?
Disease control Recruiting nowThis study is testing proton radiation as a treatment for adults with benign or slow-growing brain tumors. Researchers want to see how well it controls tumor growth and how it affects quality of life and side effects. About 100 participants will receive proton radiation and be fo…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a personalized vaccine plus targeted drug outsmart recurrent brain tumors?
Disease control Recruiting nowThis early-stage trial is testing whether combining a personalized vaccine (PEPIDH1M) with the targeted drug vorasidenib can safely and effectively treat adults with recurrent low-grade gliomas that have a specific IDH1 mutation. Participants receive the drug daily and the vaccin…
Phase 1 • Sponsor: Katy Peters, MD, PhD • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a targeted pill outperform chemotherapy for childhood brain tumors?
Disease control Recruiting nowThis trial tests whether a daily oral drug called trametinib can better control low-grade gliomas in children and young adults compared to standard weekly vinblastine chemotherapy. The study focuses on patients whose tumors do not have certain genetic changes (BRAF V600 mutation)…
Phase 2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New drug combo targets recurrent brain tumors in kids
Disease control Recruiting nowThis early-stage trial is testing the safety and best dose of two drugs, trametinib and everolimus, given together to children and young adults whose gliomas (a type of brain tumor) have come back after previous treatment. The study aims to find the highest dose that is safe and …
Phase 1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New drug cocktail aims to outsmart childhood brain tumors
Disease control Recruiting nowThis pilot study tests whether combining targeted therapy (MAPK inhibitors like trametinib and dabrafenib) with an immunotherapy drug (nivolumab) can safely and effectively treat children with BRAF-altered gliomas, a type of brain tumor. The study includes children with low-grade…
Phase 1/2 • Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Laser zaps brain tumors in kids without open surgery
Disease control Recruiting nowThis study tests a laser treatment called LITT for children, teens, and young adults whose low-grade brain tumors have come back or grown after prior therapy. About 40 participants will receive the laser procedure to heat and destroy tumor tissue. The main goal is to see how many…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New trial aims to spare young brains from radiation damage
Disease control Recruiting nowThis study is testing whether a newer type of radiation called proton therapy (IMPT) can treat children's brain tumors just as well as standard X-ray therapy (IMRT) but with fewer long-term side effects. About 94 children aged 6 to 16 with low-grade brain tumors will be randomly …
Sponsor: Tata Memorial Centre • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New vaccine aims to fight childhood brain tumors without surgery
Disease control Recruiting nowThis phase 2 trial tests a vaccine made from glioma antigen peptides combined with an immune booster (Poly-ICLC) in 25 children with recurrent low-grade gliomas that cannot be removed by surgery. The goal is to see if the vaccine can shrink tumors or keep them stable. Children wh…
Phase 2 • Sponsor: James Felker • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New trial tests if proton beam therapy spares brain function better than standard X-Rays
Disease control Recruiting nowThis phase 3 trial compares proton beam therapy to standard photon radiotherapy in 156 adults with primary brain tumors. The goal is to see if proton therapy, which delivers less radiation to healthy brain tissue, improves functional survival—meaning living longer without tumor r…
Sponsor: Tata Memorial Centre • Aim: Disease control
Last updated Jun 26, 2026 18:34 UTC
-
New imaging agent could sharpen brain tumor detection
Diagnosis Recruiting nowThis study tests a radioactive tracer called FET that lights up brain tumor cells on a PET scan. Researchers want to see if FET can better detect whether a brain tumor has come back after treatment, and help tell high-grade from low-grade tumors. About 199 people with known or su…
Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC
-
New PET-MRI tracer could sharpen view of Kids' brain tumors
Diagnosis Recruiting nowThis early-phase trial at Children's Hospital of Philadelphia is testing whether a radioactive tracer called 18F-Fluciclovine (Axumin) can improve PET-MRI scans for children and young adults with low-grade glioma. About 30 participants will receive the tracer before starting trea…
Early phase 1 • Sponsor: Children's Hospital of Philadelphia • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New software could slash MRI time for kids with brain tumors
Diagnosis Recruiting nowThis study tests a new software called Wave-CAIPI that aims to speed up MRI scans for children with low-grade gliomas. Researchers will compare the fast scans to standard ones to see if they provide the same image quality. The goal is to make imaging quicker and less stressful fo…
Sponsor: Boston Children's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:03 UTC
-
Can an iPad app boost brain power after tumor treatment?
Symptom relief Recruiting nowThis study tests three ways to help adults with low-grade glioma improve memory and attention: an iPad app (ReMind), daily health text messages, and in-person cognitive rehab. About 97 participants will try one of these programs for several weeks, and researchers will track their…
Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
Brain tumor patients may get fewer steroid side effects with tapered dosing
Symptom relief Recruiting nowThis study tests whether slowly reducing the dose of the steroid dexamethasone after brain tumor surgery can lower side effects like high blood sugar and poor wound healing, while still preventing brain swelling. About 200 adults with certain brain tumors will be randomly assigne…
Phase 2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Brain cancer survivors: can a home program boost your memory?
Symptom relief Recruiting nowThis study tests a home-based program called HOBSCOTCH-CA for brain cancer survivors who struggle with memory and thinking. The program involves weekly virtual sessions with a coach, teaching problem-solving and relaxation techniques. Researchers will compare two groups: one that…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New study maps rare brain tumors in argentina
Knowledge-focused Recruiting nowThis study looks at low-grade gliomas, a slow-growing type of brain tumor, in Argentina. Researchers will review medical records from about 40 patients to find out how common these tumors are and how long people live after diagnosis. The goal is to better understand these tumors …
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New MRI technique could reveal hidden brain tumor activity
Knowledge-focused Recruiting nowThis study tests a new type of MRI scan that uses a special substance (hyperpolarized 13C pyruvate) to see how brain tumors use energy. Researchers want to know if this scan is safe and can show changes in tumor metabolism over time. About 300 people with low-grade gliomas will b…
Phase 1 • Sponsor: Susan Chang • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Patients' voices heard: comparing brain tumor treatments through their eyes
Knowledge-focused Recruiting nowThis study looks at how people with a slow-growing brain tumor (low-grade glioma) feel during different treatments. Researchers will ask 90 patients about their quality of life, symptoms, and anxiety while they receive either the drug vorasidenib, radiotherapy, or just regular ch…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Scientists create 'Living Lab' from brain tumors to unlock treatment secrets
Knowledge-focused Recruiting nowThis study collects tumor samples from 50 adults with low- or high-grade glioma to grow mini-tumors (organoids) in the lab. Researchers will study these organoids to learn why gliomas are so hard to treat and how they spread. The goal is to create personalized 'avatars' for testi…
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Brain tumor imaging study aims to pinpoint recurrence hotspots
Knowledge-focused Recruiting nowThis study uses advanced MRI scans to better identify parts of brain tumors that are likely to grow back after standard treatment. Researchers will compare these scans with usual methods to see if they can improve radiation planning. About 135 adults with certain brain tumors wil…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Scientists map Brain's electrical response during tumor surgery
Knowledge-focused Recruiting nowThis study looks at how electrical pulses used by surgeons during awake brain surgery affect the brain. Researchers will measure brain waves in 12 people with low-grade glioma before and after tumor removal. The goal is to better understand which brain networks are turned off by …
Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC